Home
Home / For the Media / Roper St. Francis News

System News

Friday, March 25, 2022 - New cancer drug approved with support of Roper St. Francis Healthcare

Roper St. Francis Healthcare had more patients than anywhere else in the world enrolled in the clinical trial of Opdivo, which recently was approved by the federal Food and Drug Administration to treat lung cancer.

Dr. Gene Saylors with Charleston Oncology served as lead investigator for the trial.

Watch the story on Live 5 News.

eHEALTHLINK Newsletter

Subscribe today to the Roper St. Francis Healthcare monthly e-newsletter for informative articles and medical insights.

Copyright © 2022 Roper St. Francis Healthcare All rights reserved. Pencil
Back to Top